DePuy, Synthes United States LLC and Synthes Gmbh | Date: 2007-06-12
surgical implants comprising artificial or synthetic material; surgical implants comprising non-living materials; surgical implants comprising artificial or synthetic and non-living materials; surgical implants, namely, implantable nails and nailing systems made of metal, ceramics or artificial tissue for osteosynthesis; and medical and surgical instruments for use in guiding and implanting the surgical implants. medical services, namely services of surgeons in the orthopaedic field.
DePuy, Synthes United States LLC and Synthes Gmbh | Date: 2009-03-24
Surgical prostheses and implants for osteosynthesis; bone prostheses, fastening elements for bones as well as plates, nails, screws, clasps, bone pins, plates for bones (made of metal, ceramics or of artificial tissues), in particular anatomic fixation systems for use on upper parts of proximal arms, with the exception of the following goods; surgical and medical instruments and apparatus unrelated to the goods mentioned above; medical apparatus for therapeutic purposes, electrical medical apparatus and components thereof, in particular electronic apparatus for the electrical stimulation of tissues and nerves, such as heart pacemakers external or for implantation, defibrillators or cardioverters; electrodes for medical purposes; circuit discharge apparatus, cardiological diagnostic apparatus; catheters, in particular PTCA catheters; medical apparatus and systems made of these devices used to implant stents; stents; apparatus for dilation using balloons; analysis apparatus for medical purposes; apparatus for monitoring patients as well as measurement and control apparatus; artificial organs.
DePuy, Synthes United States LLC and Synthes Gmbh | Date: 2007-12-25
Surgical instruments and apparatuses for osteosyntheses, namely tools and holders and guides for tools for osteosyntheses, medical instruments for cutting and drilling bone and surgical implants comprised of metal, ceramics or living tissue, especially implantable nails and nailing system for osteosyntheses. Activities and services of surgeons, namely surgery.
DePuy, Synthes United States LLC and Synthes Gmbh | Date: 2008-02-19
Pharmaceutical products for medical purposes, namely, pharmaceutical preparations for the treatment for bone fractures; surgical implants, namely, implantable living surgical tissues, biological bone tissue intended for subsequent implantation; metal alloys for implantation purposes, namely, alloys of precious metals for osteosyntheses purposes, base metals and alloys for osteosyntheses use, shaped metals for osteosyntheses; bone cement for surgical and orthopedic uses; implants which emit medically active substances, namely, surgical implants comprising living tissue specially designed to emit medically active substances in the nature of pharmaceutical preparations for the treatment of bone diseases, anti-inflammatories, or antibiotic preparations; implants which emit medically active substances, namely, avital processed human or animal connective tissue specially designed to emit medically active substances in the nature of pharmaceutical preparations for the treatment of bone diseases, anti-inflammatories, or antibiotic preparations. Measuring instruments for laboratories for medical purposes, namely, rheometers or viscometers for measuring the viscosity and viscoelasticity of bone cements, medical measuring instruments, namely, measuring instruments for measuring the viscosity of various medical materials and measuring instruments for measuring the viscosity of bone cements. Surgical, medical, dental and veterinary apparatus and instruments, namely, surgical and medical apparatus and instruments for use in general surgery, surgical blades, surgical compresses, autoclaves for medical use, medical instruments for cutting tissue, surgical implants comprising artificial metal material; surgical implants comprising artificial ceramic material; surgical implants comprising artificial material; surgical instruments, namely, surgical apparatus for use in general or orthopedic surgery for positioning bone cement in the living body and for positioning bone cement in or on bones respectively.
The global market for spinal non-fusion treatments will expand from just under $521 million in 2014 to $749 million by 2021, at a Compound Annual Growth Rate (CAGR) of 5.3%, according to research and consulting firm GlobalData. The company’s latest report states that this moderate growth will be driven primarily by the promising Cervical Total Disc Replacement (C-TDR) segment, due to an increasing availability of clinical efficacy data, the rising prevalence of degenerative spine diseases and the industry’s aggressive efforts in relation to physician training and direct-to-consumer marketing. C-TDR is the fastest-growing segment in the spinal care market, as it has shifted from being considered an investigational surgery to a viable alternative to Anterior Cervical Discectomy and Fusion (ACDF). In general, using C-TDR in the right patients has been shown to reduce the rate of reoperations, deliver higher rates of clinical success, and reduce costs as compared to ACDF. Other growth drivers for C-TDR include improving reimbursement for the procedures in most major markets and an aging patient population that is more well-informed and demanding of motion preservation than ever before. Over the past decade, the number of C-TDR devices has proliferated and such products are now available in various shapes, materials, and biomechanical concepts. Despite the clear advantages opting for disc replacement non-fusion options can offer, its widespread adoption still faces barriers. Generally, large companies have avoided these technologies in light of stringent government and insurance company regulations. They seem to be more interested in acquiring the technology once it has been designed and approved. GlobalData’s report also states that an increase in mergers and acquisitions activity is a trend that is likely to persist over the next five years. Market-leading companies, such as DePuy Synthes and Medtronic, initially entered the non-fusion market through acquisitions. Since then, a league of small- to medium-sized companies have internally developed and marketed their artificial discs or other non-fusion technologies. Although DePuy is likely to dominate the spinal non-fusion arena during the forecast period, the artificial disc replacement market will continue to attract new entrants.